A database of glucosinolate structures and secondary mass spectrometry database, construction method and application

By constructing a high-coverage database of glucosinolate structures and its theoretical secondary mass spectrometry database, the problem of insufficient analysis of glucosinolate samples in existing technologies has been solved, and efficient annotation and identification of glucosinolate compounds in complex samples has been achieved.

CN122455159APending Publication Date: 2026-07-24WUHAN BOTANICAL GARDEN CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610528392.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-04-21
Publication Date
2026-07-24

AI Technical Summary

Technical Problem

Existing technologies are insufficient for the systematic analysis of glucosinolate components in complex plant samples. The number of commercially available standards is limited, existing mass spectrometry databases have insufficient coverage, and there is a lack of systematic secondary mass spectrometry information on glucosinolates.

Method used

A comprehensive database of glucosinolate structures and its corresponding theoretical secondary mass spectrometry database were constructed. By combining reported structural information, biosynthetic rules, and fragmentation rules of standard mass spectrometry data, the structure set was expanded and the mass spectra were integrated to establish a glucosinolate secondary mass spectrometry database.

Benefits of technology

It significantly improves the annotation efficiency and coverage of glucosinolate compounds in complex samples, and enhances the recognition ability of glucosinolates.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122455159A_ABST
    Figure CN122455159A_ABST
Patent Text Reader

Abstract

The application discloses a kind of thioglucoside structure database and the construction method of secondary mass spectrum database, comprising: collecting thioglucoside structure establishes initial thioglucoside structure set;According to the biosynthesis pathway of thioglucoside and side chain modification mode, potential thioglucoside structure set is generated by structure expansion, and thioglucoside structure database is established;Obtain the experimental secondary mass spectrum data of multiple thioglucoside standard, and the mass spectrum fragmentation law of thioglucoside is summarized, and the secondary mass spectrum fragmentation rule model of thioglucoside is established;Theoretical secondary mass spectrum of all thioglucoside structures in thioglucoside structure database is predicted, and the secondary mass spectrum database of thioglucoside is constructed.The application constructs the thioglucoside structure database with very high coverage and its corresponding theoretical secondary mass spectrum database, can significantly improve the annotation efficiency and coverage of thioglucoside compound in complex sample.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of plant metabolomics and mass spectrometry data analysis, specifically to a method and application for constructing a glucosinolate structure database and a secondary mass spectrometry database. Background Technology

[0002] Glucosinolates (GSLs), also known as thioglycosides, are a class of sulfur-containing secondary metabolites widely found in cruciferous plants, playing important roles in plant disease resistance, defense, and food flavor formation. Glucosinolate molecules typically consist of three parts: a β-D-thioglucose group, a sulfonic acid oxime group, and an R-group side chain derived from amino acid metabolic pathways. Based on the origin of the side chain, glucosinolates are generally classified into three main categories: aliphatic, aromatic, and indole glucosinolates.

[0003] In recent years, high-resolution liquid chromatography-tandem mass spectrometry (LC-MS / MS) has become an important technique for the detection of glucosinolates and metabolomics research. Current studies largely rely on commercially available glucosinolate standards, achieving qualitative and quantitative analysis of glucosinolates through comparison of retention times and secondary mass spectrometry fragmentation information. However, the number of commercially available glucosinolate standards is limited, covering only a small portion of reported glucosinolate compounds, thus failing to meet the needs for systematic analysis of glucosinolate components in complex plant samples.

[0004] Furthermore, most publicly available mass spectrometry databases are general metabolite databases, with a significant lack of dedicated mass spectrometry databases for glucosinolates. Existing databases also have limited structural coverage and lack systematic secondary mass spectrometry information for glucosinolates. Therefore, in non-targeted metabolomics research, current techniques struggle to systematically annotate glucosinolates in complex samples. How to construct a more comprehensive glucosinolate structure and secondary mass spectrometry database based on existing reports, thereby improving the identification and annotation capabilities of glucosinolate compounds in plant samples, has become a pressing technical problem to be solved in current glucosinolate metabolomics research. Summary of the Invention

[0005] The technical problem to be solved by the present invention is to provide a glucosinolate structure database and a secondary mass spectrometry database, a construction method and application, which address the shortcomings of the prior art. The method constructs a glucosinolate structure database with extremely high coverage and its corresponding theoretical secondary mass spectrometry database by combining reported structural information, structural expansion based on biosynthetic rules and fragmentation rule extraction based on standard mass spectrometry data, which can significantly improve the annotation efficiency and coverage of glucosinolate compounds in complex samples.

[0006] To achieve the above objectives, according to one aspect of the present invention, a method for constructing a glucosinolate structure database and a secondary mass spectrometry database is provided, comprising: Collect glucosinolate structures and establish an initial set of glucosinolate structures; Based on the biosynthetic pathway and side chain modification mode of glucosinolates, the initial set of glucosinolate structures is expanded to generate a set of potential glucosinolate structures. Based on the initial set of glucosinolate structures and the potential set of glucosinolate structures, a glucosinolate structure database is established. We obtained experimental secondary mass spectrometry data of various glucosinolate standards, summarized the mass spectrometry fragmentation rules of glucosinolates, and established a secondary mass spectrometry fragmentation rule model of glucosinolates. Based on the fracturing rule model of glucosinolate secondary mass spectrometry, theoretical secondary mass spectra of all glucosinolate structures in the glucosinolate structure database are predicted. Theoretical secondary mass spectra are then obtained by integrating the glucosinolate structure database with the theoretical secondary mass spectra to construct a glucosinolate secondary mass spectrometry database.

[0007] In the above scheme, the structural expansion of the initial set of glucosinolate structures includes: Structural extension is performed based on thioglucosides from different precursor amino acid sources. The structural extension includes side chain carbon chain elongation and / or secondary side chain modification. The secondary side chain modification includes one or more of oxidation, desaturation, hydroxylation, methoxylation, sulfurization, and glycosylation. The different types of thioglucosides from different precursor amino acid sources include aliphatic thioglucosides, aromatic thioglucosides, and indole thioglucosides.

[0008] In the above scheme, the aliphatic glucosinolate undergoes side chain carbon chain extension within the C1~C12 range; the aromatic glucosinolate undergoes side chain carbon chain extension within the C1~C6 range.

[0009] In the above scheme, the acquisition of experimental secondary mass spectrometry data of various glucosinolate standards, the summarization of the mass spectrometry fragmentation rules of glucosinolates, and the establishment of a secondary mass spectrometry fragmentation rule model for glucosinolates include: Experimental secondary mass spectrometry data of various glucosinolate standards, including aliphatic, aromatic, and indole glucosinolates, were obtained. The secondary mass spectrometry fragmentation characteristics of different types of glucosinolates were summarized, and the common skeletal diagnostic ions and neutral loss ions related to side chain modifications were identified. Based on the skeletal diagnostic ions and their relative abundance information and the neutral loss ions and their relative abundance information, a secondary mass spectrometry fragmentation rule model for glucosinolates was established.

[0010] In the above scheme, the common scaffold diagnostic ions of the glucosinolates include: [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [HSO4] - [SO4] - [SO3] - [C2H3OS] - [HSO4] - The ion peak is the base peak, [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [SO4] - [SO3] - [C2H3OS] - The relative abundances were 2%–6%, 5%–20%, 4%–9%, ​​8%–25%, 4%–10%, and 7%–25%, respectively. The neutral loss ions associated with the side chains include [MH-SO3]. - [MH-SO3-C6H] 10 O5] - [MH-SC6H] 10 O4] - and [MH-SC6H 12 O5] - Their relative abundances were 0.5%~5%, 4%~10%, 1%~3% and 3%~10%, respectively.

[0011] In the above scheme, the neutral loss ions associated with the side chain also include: [MH-CH3SOH] produced from methylsulfinyl alkyl aliphatic glucosinolates - and [MH-CH3SOH-SC6H 10 O5] - [MH-OCH3] is produced by methoxy substitution in ionic and indole-type thioglucosinolates. - ion; [MH-CH3SOH] - The relative abundance is 50%~70%, [MH-CH3SOH-SC6H 10 O5] -The relative abundance of [MH-OCH3] is 5%–20%. - The relative abundance is 12% to 22%.

[0012] In the above scheme, the step of predicting theoretical secondary mass spectra of all glucosinolate structures in the glucosinolate structure database based on the glucosinolate secondary mass spectrometry fragmentation rule model to obtain theoretical secondary mass spectra; and integrating the glucosinolate structure database and the theoretical secondary mass spectra to construct the glucosinolate secondary mass spectrometry database includes: Based on the molecular formulas of all glucosinolate structures in the aforementioned glucosinolate structure database, calculate their deprotonated precursor ion [MH]. - The precise mass-to-charge ratio serves as precursor ion information for theoretical second-order mass spectrum simulation; Based on the fracturing rule model of the thioglucosinolate secondary mass spectrometry, theoretical secondary mass spectra of all thioglucosinolate structures in the thioglucosinolate structure database are predicted, and corresponding precursor ions, common skeleton diagnostic ions of thioglucosinolates, and neutral loss ions related to side chain modification and their relative abundance information are generated to obtain theoretical secondary mass spectra. The structural information of glucosinolates in the glucosinolate structure database is integrated with the information in the theoretical secondary mass spectrometry to construct a glucosinolate secondary mass spectrometry database.

[0013] In the above scheme, each record in the glucosinolate structure database contains one or more of the following information: chemical structure, molecular formula, precise molecular mass, chemical nomenclature, structural classification, biosynthetic precursor, SMILES information, and InChIKey information.

[0014] In the above scheme, the collection of glucosinolate structures includes: Reported glucosinolate structures were collected from publicly available literature and databases, including one or more of PubChem, COCONUT, SuperNatural, and The Natural Products Atlas.

[0015] To achieve the above objectives, according to another aspect of the present invention, a glucosinolate secondary mass spectrometry database is provided. This database is constructed using the aforementioned method for constructing a glucosinolate structural database and a secondary mass spectrometry database. The glucosinolate secondary mass spectrometry database contains structural information of multiple glucosinolate compounds and their corresponding theoretical secondary mass spectra, specifically including: compound name, molecular formula, SMILES, InChIKey, precise mass-to-charge ratio of precursor ions, mass-to-charge ratio of characteristic fragment ions, and their relative abundance information.

[0016] To achieve the above objectives, according to another aspect of the present invention, a method for annotating glucosinolate compounds is provided, comprising: Acquire liquid chromatography-tandem mass spectrometry data of the plant samples to be tested; The mass spectrometry data is matched with a glucosinolate secondary mass spectrometry database, and the glucosinolate compounds in the plant samples to be tested are annotated according to the matching results. The matching process includes: comparing the precise mass-to-charge ratio of the precursor ions, comparing the consistency between the measured secondary mass spectrum and the theoretical secondary mass spectrum information of the glucosinolate secondary mass spectrometry database, and filtering the annotation results according to a preset scoring threshold.

[0017] This invention also provides the application of the above-mentioned glucosinolate secondary mass spectrometry database in plant metabolomics, glucosinolate structure determination, or mass spectrometry data analysis.

[0018] In summary, compared with the prior art, the above-described technical solutions conceived by this invention can achieve the following beneficial effects: (1) This invention provides a method for constructing a glucosinolate structure database and a secondary mass spectrometry database. This method constructs a glucosinolate structure database with extremely high coverage and its corresponding theoretical secondary mass spectrometry database by combining reported structural information, structural expansion based on biosynthetic rules, and fragmentation rule extraction based on standard mass spectrometry data. This makes up for the lack of a comprehensive glucosinolate-specific mass spectrometry database in existing public resources.

[0019] (2) The database provided by the present invention can be used for mass spectrometry data matching and annotation of glucosinolate compounds in plant samples, which improves the annotation coverage and identification efficiency of glucosinolate compounds in complex samples. Attached Figure Description

[0020] Various other advantages and benefits will become apparent to those skilled in the art upon reading the following detailed description of preferred embodiments. The accompanying drawings are for illustrative purposes only and are not intended to limit the invention. Furthermore, the same reference figures denote the same parts throughout the drawings. In the drawings: Figure 1 This is a flowchart illustrating a method for constructing a glucosinolate structure database and a secondary mass spectrometry database in Embodiment 1 of the present invention.

[0021] Figure 2 This is a comparison chart of the reported structures of glucosinolates in Example 1 of the present invention and the number of classifications in the expanded structure database.

[0022] Figure 3 This is a schematic diagram of the general property spectrum fragmentation rules of glucosinolates in Example 1 of the present invention.

[0023] Figure 4 Figure 2 shows the annotation results of glucosinolates in cruciferous plants in Example 2 of the present invention. Figure (A) shows the cruciferous plant materials used for glucosinolate determination; Figure (B) shows the number and types of different cruciferous plants annotated by the glucosinolate mass spectrometry database; Figure (C) is a comparison of the annotation results of GNPS and the glucosinolate mass spectrometry database. Detailed Implementation

[0024] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the invention. Furthermore, the technical features involved in the various embodiments of this invention described below can be combined with each other as long as they do not conflict with each other.

[0025] It should be understood that the sequence number of each step in the embodiment does not imply the order of execution. The execution order of each process should be determined by its function and internal logic, and should not constitute any limitation on the implementation process of the embodiments of this application.

[0026] Example 1 This application provides a method for constructing a glucosinolate structure database and a secondary mass spectrometry database. Please refer to [link to relevant documentation]. Figure 1 ,include: S1, collect glucosinolate structures and establish an initial set of glucosinolate structures.

[0027] In this embodiment, the collection of glucosinolate structures includes: collecting reported glucosinolate structures from publicly available literature and databases, including one or more of PubChem, COCONUT, SuperNatural, and The Natural Products Atlas.

[0028] Specifically, in this embodiment, the first step is to collect reported glucosinolate structural information. This embodiment collects reported glucosinolate structural information by searching published literature and public databases such as PubChem, COCONUT, SuperNatural, and The Natural Products Atlas. During the search, this embodiment uses the core skeleton of glucosinolates as a basis for structural screening to obtain candidate glucosinolate entries. The collected candidate glucosinolate entries are then uniformly organized and manually verified, removing entries with different charge states, different addition forms, duplicate entries, and entries that do not meet the basic skeleton characteristics of glucosinolates. Entries that differ only in stereochemistry but have the same side chain composition are merged according to the same side chain structure to obtain an initial set of glucosinolate structures with unique side chain characteristics. In this embodiment, a total of 186 reported glucosinolate structures were obtained.

[0029] S2, based on the biosynthetic pathway and side chain modification pattern of glucosinolates, expands the initial set of glucosinolate structures to generate a set of potential glucosinolate structures.

[0030] In this embodiment, structural expansion of the initial set of glucosinolate structures includes: Structural extensions were performed based on thioglucosides derived from different precursor amino acid sources. These structural extensions included side chain carbon chain elongation and secondary side chain modifications, including oxidation, desaturation, hydroxylation, methoxylation, sulfurization, and glycosylation.

[0031] Specifically, in this embodiment, based on the 186 reported glucosinolate structures, according to their biosynthetic rules, the structures of glucosinolates (aliphatic glucosinolates, aromatic glucosinolates, and indole glucosinolates) from different precursor amino acid sources were systematically extended. The C1-C12 side chain carbon chains of aliphatic structures were extended, and the C1-C6 side chain carbon chains of aromatic structures were extended. All structures were subjected to secondary modifications such as oxidation, desaturation, hydroxylation, methoxylation, sulfurization, and glycosylation, ultimately generating 1732 glucosinolate structures and a potential glucosinolate structure set.

[0032] S3. Based on the initial set of glucosinolate structures and the potential set of glucosinolate structures, a glucosinolate structure database is established.

[0033] In this embodiment, the initial set of glucosinolate structures and the potential set of glucosinolate structures are integrated to establish a glucosinolate structure database. Each record in the glucosinolate structure database contains the following information: chemical structure, molecular formula, precise molecular weight, n-octanol / water partition coefficients (logP), chemical category, precursor amino acid source, InChIKey, and SMILES information. In this embodiment, the constructed glucosinolate structure database contains a total of 1918 glucosinolate structures, specifically as follows: Figure 2 As shown.

[0034] S4. Obtain experimental secondary mass spectrometry data of various glucosinolate standards, summarize the mass spectrometry fragmentation rules of glucosinolates, and establish a secondary mass spectrometry fragmentation rule model of glucosinolates.

[0035] In this embodiment, experimental secondary mass spectrometry data of various glucosinolate standards covering aliphatic, aromatic, and indole groups were obtained. The secondary mass spectrometry fragmentation characteristics of different types of glucosinolates were summarized, and the common skeletal diagnostic ions and neutral loss ions related to side chain modifications were identified. Based on the skeletal diagnostic ions and their relative abundance information and the neutral loss ions and their relative abundance information, a secondary mass spectrometry fragmentation rule model for glucosinolates was established.

[0036] Specifically, in this embodiment, the following 18 representative glucosinolate standards were selected, including aliphatic glucosinolates, aromatic glucosinolates, and indole glucosinolates, including: methyl GSL (glucocapparin, 51), prop-2-enyl GSL (sinigrin, 107), pent-4-enyl GSL (glucobrassicanapin, 101), 2-hydroxybut-3-enyl GSL (progoitrin, 24), 4-(methylthio)butyl GSL (glucoerucin, 84), 5-(methylthio)pentyl GSL (glucoberteroin, 94), 3-(methylsulfonyl)propyl GSL (glucocheirolin, 82), 4-(methylsulfinyl)but-3-enyl GSL (glucoraphenin, 63), 3-(methylsulfinyl)propyl GSL (glucoiberin, 51), 5-hydroxybut-3-enyl GSL (glucocappar ... 73), 4-(methylsulfinyl)butyl GSL (glucoraphanin, 64), 10-(methylsulfinyl)decyl GSL (glucocamelinin, 65), benzyl GSL (glucotropaeolin, 11), 4-hydroxybenzyl GSL (sinalbin, 23), 2-hydroxy-2-phenylethyl GSL (glucobarbarin, 40), indol-3-ylmethyl GSL (glucobrassicin, 43), 1-methoxyindol-3-ylmethyl GSL (neoglucobrassicin, 47), 4-methoxyindol-3-ylmethyl GSL (4-methoxyglucobrassicin, 48), 4-hydroxyindol-3-ylmethyl GSL (4-hydroxyglucobrassicin, 28).

[0037] Weigh appropriate amounts of the above 18 glucosinolate standards, dissolve them in 50% (v / v) methanol aqueous solution, and mix them by vortexing and sonication to prepare standard stock solutions with a concentration of 1 mg / mL. Then, take 5 μL of each standard stock solution and add 995 μL of 50% (v / v) methanol aqueous solution to prepare single-component standard solutions with a concentration of 5 μg / mL.

[0038] This embodiment uses an ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HMS) system to separate and detect the above-mentioned glucosinolate standards. Specifically, the liquid chromatography system used in this embodiment is a Vanquish UHPLC system (Thermo Scientific, USA), and the high resolution mass spectrometer is a Q-Exactive HFx mass spectrometer (equipped with a HESI-II ion source, Thermo Scientific, USA). The samples to be analyzed are separated using a Waters Acquity UPLC CSH C18 column (2.1 mm × 100 mm, 1.7 μm), with the column temperature set at 40 ℃, the sample tray temperature set at 4 ℃, and the injection volume at 2 μL. Mobile phase A is an aqueous solution containing 10 mM ammonium acetate, mobile phase B is acetonitrile, and the flow rate is 0.4 mL / min. The gradient elution program was set as follows: 0 min, 5% B; 3 min, 30% B; 4 min–5 min, 80% B; 5.1 min–7.5 min, 100% B; 7.7 min, 50% B; 8.5 min–10.5 min, 5% B. Mass spectrometry acquisition used a data-dependent acquisition mode in negative ion mode. Ion source parameters were set as follows: spray voltage 3.7 kV, sheath gas flow rate 30 arb, auxiliary gas flow rate 10 arb, capillary temperature 320 ℃, and auxiliary gas heater temperature 400 ℃. The full scan mass range for the first-stage mass spectrometry was 300–1000 m / z, with a resolution of 60,000; the resolution for the second-stage mass spectrometry was 15,000, the isolation window was 1.0 m / z, and the normalized collision energy was 25%. The acquired mass spectrometry data were processed using Thermo Xcalibur Qual Browser 4.5.18 software.

[0039] This embodiment analyzes the secondary mass spectrometry data of the above 18 glucosinolate standards, summarizes the fragmentation characteristics of secondary mass spectrometry for different types of glucosinolates, and concludes the common skeletal diagnostic ions and neutral loss ion patterns related to side chain modifications of glucosinolates, such as... Figure 3 As shown. The common skeletal diagnostic ions of glucosinolates identified include: [C6H... 11 O8S2] - [C6H]11 O9S] - [C6H] 11 O5S] - [HSO4] - [SO4] - [SO3] - [C2H3OS] - [HSO4] - The ion peak is the base peak, [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [SO4] - [SO3] - [C2H3OS] - The relative abundances of these ions were approximately 5%, 10%, 8%, 20%, 8%, and 20%, respectively. These ions can serve as characteristic fragment ions for determining whether a compound possesses a glucosinolate core skeleton, and are a key basis for identifying whether an unknown compound is a glucosinolate. The neutral loss ions associated with the side chain identified include [MH-SO3]. - [MH-SO3-C6H] 10 O5] - [MH-SC6H] 10 O4] - and [MH-SC6H 12 O5] - The relative abundances of these ions are approximately 2%, 10%, 2%, and 3%–10%, respectively. These neutral loss ions provide information about the side chain structure of glucosinolates, allowing for the inference of the side chain composition, linkage mode, and modification status. Furthermore, [MH-CH3SOH] can also be generated in methylsulfinyl alkyl aliphatic glucosinolates. - and [MH-CH3SOH-SC6H 10 O5] - The former has a relative abundance of approximately 60%, while the latter has a relative abundance of approximately 5%–20%; methoxy substitution in indole-based glucosinolates can produce [MH-OCH3]. - Its relative abundance is approximately 20%.

[0040] Based on the shared backbone diagnostic ions, neutral loss ions, and their relative abundance information of the above-mentioned glucosinolates, a secondary mass spectrometry fragmentation rule model for glucosinolates is established for subsequent prediction of theoretical secondary mass spectra of glucosinolates and construction of a mass spectrometry database.

[0041] Specifically, the secondary mass spectrometry fragmentation rule model for glucosinolates in this embodiment can predict the major fragments of a given unknown glucosinolate structure: (1) Required peak (common framework diagnostic ion): The predicted chromatogram must contain m / z 96.9601 [HSO4]. - As a base peak, and possibly [C6H] 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [SO4] - [SO3] - [C2H3OS] - Isoskeleton ions, [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [SO4] - [SO3] - [C2H3OS] - The relative abundances were 2%–6%, 5%–20%, 4%–9%, ​​8%–25%, 4%–10%, and 7%–25%, respectively. (2) Neutral loss ion loss peaks related to side chains: The forecast includes at least [MH-SO3]. - [MH-SO3-C6H] 10 O5] - [MH-SC6H] 10 O4] - and [MH-SC6H 12 O5] - The relative abundances of one of the four neutral loss ions are 0.5%–5%, 4%–10%, 1%–3%, and 3%–10%, respectively. (3) Side chain characteristic peaks: Methylsulfinyl alkyl aliphatic glucosinolates: [MH-CH3SOH] are predicted to be present. - and [MH-CH3SOH-SC6H 10 O5] - The characteristic peaks of the former are 50%–70% in relative abundance and 5%–20% in relative abundance. Methoxy-substituted structures in indole-based glucosinolates: [MH-OCH3] is predicted. -The characteristic peaks of the α-thallium have a relative abundance of 12% to 22%.

[0042] S5. Based on the fragmentation rule model of glucosinolate secondary mass spectrometry, theoretical secondary mass spectra of all glucosinolate structures in the glucosinolate structure database are predicted. The theoretical secondary mass spectra are then obtained by integrating the glucosinolate structure database and the theoretical secondary mass spectra to construct a glucosinolate secondary mass spectrometry database.

[0043] In this embodiment, firstly, based on the constructed glucosinolate structure database, the deprotonated precursor ion [MH] of each glucosinolate compound is calculated according to its molecular formula. - The precise mass-to-charge ratio is used as precursor ion information for theoretical second-order mass spectrum simulation.

[0044] Subsequently, based on the established secondary mass spectrometry fragmentation rule model of glucosinolates, theoretical secondary mass spectrometry predictions were performed on all glucosinolate entries in the glucosinolate structure database to generate corresponding precursor ions, common skeleton diagnostic ions of glucosinolates, and neutral loss ions related to side chain modifications, as well as their relative abundance information.

[0045] The structural information of glucosinolates in the glucosinolate structure database is integrated with the information in the theoretical secondary mass spectrometry to construct a glucosinolate secondary mass spectrometry database.

[0046] In this embodiment, the glucosinolate secondary mass spectrometry database contains structural information and corresponding theoretical secondary mass spectra of 1918 glucosinolate compounds, specifically including: compound name, molecular formula, SMILES, InChIKey, precise mass-to-charge ratio of precursor ions, mass-to-charge ratio of characteristic fragment ions, and their relative abundance information. In this embodiment, the glucosinolate secondary mass spectrometry database automatically generates .msp format files according to a preset template, which is an Excel template with embedded VBA scripts. The generated .msp format database can be used for database matching analysis in metabolomics data processing software; it can also be converted to other standard mass spectrometry library formats.

[0047] In summary, this embodiment provides a method for constructing a glucosinolate structure database and a secondary mass spectrometry database. This method constructs a glucosinolate structure database with extremely high coverage and its corresponding theoretical secondary mass spectrometry database by combining reported structural information, structural expansion based on biosynthetic rules, and fragmentation rule extraction based on standard mass spectrometry data. This makes up for the lack of a comprehensive glucosinolate-specific mass spectrometry database in existing public resources.

[0048] Example 2 One embodiment of this application provides a method for annotating glucosinolate compounds, including: Acquire liquid chromatography-tandem mass spectrometry data of the plant samples to be tested; Mass spectrometry data were matched with a glucosinolate secondary mass spectrometry database from Example 1, and glucosinolate compounds in the plant samples to be tested were annotated based on the matching results. The matching process includes: comparing the precise mass-to-charge ratio of the precursor ions, comparing the consistency between the measured secondary mass spectrum and the theoretical secondary mass spectrum information of a glucosinolate secondary mass spectrometry database in Example 1, and filtering the annotation results based on a preset scoring threshold.

[0049] This embodiment illustrates the annotation capability of the glucosinolate secondary mass spectrometry database described in Example 1 in actual plant samples and demonstrates its application differences in different tissue types. Specifically, this embodiment applies it to the annotation of glucosinolates in cruciferous plant samples to verify the actual application effect of the database. The specific steps are as follows: (1) Preparation of plant samples A variety of representative cruciferous plant materials were selected as the analysis objects, including leaves and stems of Chinese cabbage, kale, bok choy, rapeseed, and mustard; flower heads and pedicels of cauliflower and broccoli; fleshy taproots of white radish, green radish, and red radish; leaves of Arabidopsis thaliana and rapeseed; and rapeseed. For sample preparation, 100 mg of fresh plant tissue was weighed and placed in a 2 mL grinding tube. 1 mL of pre-cooled 80% (v / v) methanol aqueous solution was added, along with grinding beads, for homogenization. After homogenization, the mixture was incubated on ice for 15 min, then centrifuged at low temperature. 300 μL of the supernatant was transferred to a new centrifuge tube, vacuum-centrifuged and dried, and stored at -20 °C for subsequent liquid chromatography-mass spectrometry analysis. In this embodiment, the sample pretreatment process was carried out under low temperature conditions to inhibit endogenous myrosinase activity and reduce glucosinolate degradation.

[0050] (2) Mass spectrometry data acquisition The sample extract was analyzed using a liquid chromatography-high resolution mass spectrometry (LC-HMS) system to obtain primary and secondary mass spectrometry data. In this embodiment, the LC-HMS analysis conditions were the same as those in Example 1.

[0051] (3) Data matching and glucosinolate annotation The acquired mass spectrometry data were imported into the metabolomics data processing software (MS-DIAL) for peak extraction, peak alignment, feature identification, and database matching. The glucosinolate secondary mass spectrometry database from Example 1 was selected as a reference library for annotation. In this example, deprotonated ions [MH] were used for annotation. -As matching ions, a comprehensive matching process is performed, combining the precise mass-to-charge ratio of the precursor ions and secondary mass spectra information. In this embodiment, mass tolerances for precursor ions, fragment ions, and retention times are set during the matching process, and annotation scoring thresholds are defined to improve the reliability of the annotation results. Finally, the annotation results are exported as a text file, including information such as the name of the annotated glucosinolate compound, its mass-to-charge ratio, annotation score, and peak intensity.

[0052] (4) Annotation results and verification In this embodiment, as Figure 4 As shown, 13 cruciferous plant materials were used as the analysis objects. Matching analysis was performed using the glucosinolate mass spectrometry database in Example 1, resulting in the annotation of 107 endogenous glucosinolates. Aliphatic glucosinolates dominated in both quantity and structural type, accounting for approximately 75% of all annotated glucosinolates. In addition, 13 aromatic glucosinolates and 14 indole glucosinolates were also annotated. Of the 107 annotated results, 36 were candidate structures not yet reported in the literature, indicating that the high-coverage glucosinolate structure database and secondary mass spectrometry database constructed using this invention can expand the annotation range of glucosinolate compounds in plant samples.

[0053] To evaluate the annotation performance of the constructed glucosinolate secondary mass spectrometry database in actual samples, this embodiment further compares the annotation results with those of a public mass spectrometry platform. The public mass spectrometry platform used in this embodiment is the GNPS platform. When annotating the same batch of mass spectrometry data using the public mass spectrometry platform, a total of 23 glucosinolate annotation results were obtained, and all 23 structures can be covered and annotated by the glucosinolate mass spectrometry database. In addition, based on the glucosinolate secondary mass spectrometry database constructed in this invention, an additional 84 glucosinolate annotation results were obtained, including 48 structures reported in the literature and 36 candidate structures not yet reported in the literature. Furthermore, 13 of the above annotation results were confirmed by comparison with the retention time, precise molecular weight, and secondary mass spectra of the corresponding standards. The above results indicate that the glucosinolate structure database and secondary mass spectrometry database constructed in this invention can improve the number and coverage of glucosinolate compounds in complex plant samples and have good practical application value.

[0054] It should be noted that, depending on the implementation needs, the various steps described in this application can be broken down into more steps, or two or more steps or parts of the steps can be combined into new steps to achieve the purpose of this invention.

[0055] Those skilled in the art will readily understand that the above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A method for constructing a glucosinolate structure database and a secondary mass spectrometry database, characterized in that, include: Collect glucosinolate structures and establish an initial set of glucosinolate structures; Based on the biosynthetic pathway and side chain modification mode of glucosinolates, the initial set of glucosinolate structures is expanded to generate a set of potential glucosinolate structures. Based on the initial set of glucosinolate structures and the potential set of glucosinolate structures, a glucosinolate structure database is established. We obtained experimental secondary mass spectrometry data of various glucosinolate standards, summarized the mass spectrometry fragmentation rules of glucosinolates, and established a secondary mass spectrometry fragmentation rule model of glucosinolates. Based on the fracturing rule model of glucosinolate secondary mass spectrometry, theoretical secondary mass spectra of all glucosinolate structures in the glucosinolate structure database are predicted. Theoretical secondary mass spectra are then obtained by integrating the glucosinolate structure database with the theoretical secondary mass spectra to construct a glucosinolate secondary mass spectrometry database.

2. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 1, characterized in that, The structural expansion of the initial set of glucosinolate structures includes: Structural extension is performed based on thioglucosides from different precursor amino acid sources. The structural extension includes side chain carbon chain elongation and / or secondary side chain modification. The secondary side chain modification includes one or more of oxidation, desaturation, hydroxylation, methoxylation, sulfurization, and glycosylation. The different types of thioglucosides from different precursor amino acid sources include aliphatic thioglucosides, aromatic thioglucosides, and indole thioglucosides.

3. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 2, characterized in that, The aliphatic glucosinolate undergoes side chain carbon chain elongation within the C1-C12 range; the aromatic glucosinolate undergoes side chain carbon chain elongation within the C1-C6 range.

4. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 1, characterized in that, The process of obtaining secondary mass spectrometry data of various glucosinolate standards, summarizing the mass spectrometry fragmentation rules of glucosinolates, and establishing a secondary mass spectrometry fragmentation rule model for glucosinolates includes: Experimental secondary mass spectrometry data of various glucosinolate standards, including aliphatic, aromatic, and indole glucosinolates, were obtained. The secondary mass spectrometry fragmentation characteristics of different types of glucosinolates were summarized, and the common skeletal diagnostic ions and neutral loss ions related to side chain modifications were identified. Based on the skeletal diagnostic ions and their relative abundance information and the neutral loss ions and their relative abundance information, a secondary mass spectrometry fragmentation rule model for glucosinolates was established.

5. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 1, characterized in that, The common skeletal diagnostic ions of the glucosinolates include: [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [HSO4] - [SO4] - [SO3] - [C2H3OS] - [HSO4] - The ion peak is the base peak, [C6H 11 O8S2] - [C6H] 11 O9S] - [C6H] 11 O5S] - [SO4] - [SO3] - [C2H3OS] - The relative abundances were 2%–6%, 5%–20%, 4%–9%, ​​8%–25%, 4%–10%, and 7%–25%, respectively. The neutral loss ions associated with the side chains include [MH-SO3]. - [MH-SO3-C6H] 10 O5] - [MH-SC6H] 10 O4] - and [MH-SC6H 12 O5] - Their relative abundances were 0.5%~5%, 4%~10%, 1%~3% and 3%~10%, respectively.

6. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 5, characterized in that, The side-chain-related neutral loss ions also include: [MH-CH3SOH] produced from methylsulfinyl alkyl aliphatic glucosinolates - and [MH-CH3SOH-SC6H 10 O5] - [MH-OCH3] is produced by methoxy substitution in ionic and indole-type thioglucosinolates. - ion; [MH-CH3SOH] - The relative abundance is 50%~70%, [MH-CH3SOH-SC6H 10 O5] - The relative abundance of [MH-OCH3] is 5%–20%. - The relative abundance is 12% to 22%.

7. The method for constructing a glucosinolate structure database and a secondary mass spectrometry database according to claim 1, characterized in that, The theoretical secondary mass spectra are obtained by predicting the theoretical secondary mass spectra of all thioglucosides in the thioglucosides structure database based on the fragmentation rule model of the thioglucosides secondary mass spectra. Integrating the aforementioned glucosinolate structure database with the aforementioned theoretical secondary mass spectra, the construction of a glucosinolate secondary mass spectrometry database includes: Calculate the deprotonated precursor ion [MH] based on the molecular formulas of all glucosinolate structures in the aforementioned glucosinolate structure database. - The precise mass-to-charge ratio serves as precursor ion information for theoretical second-order mass spectrum simulation; Based on the fracturing rule model of the thioglucosinolate secondary mass spectrometry, theoretical secondary mass spectra of all thioglucosinolate structures in the thioglucosinolate structure database are predicted, and corresponding precursor ions, common skeleton diagnostic ions of thioglucosinolates, and neutral loss ions related to side chain modification and their relative abundance information are generated to obtain theoretical secondary mass spectra. The structural information of glucosinolates in the glucosinolate structure database is integrated with the information in the theoretical secondary mass spectrometry to construct a glucosinolate secondary mass spectrometry database.

8. A secondary mass spectrometry database for glucosinolates, characterized in that, The database is constructed using the method described in any one of claims 1-7 for constructing a glucosinolate structure database and a secondary mass spectrometry database. The glucosinolate secondary mass spectrometry database contains structural information of multiple glucosinolate compounds and their corresponding theoretical secondary mass spectra, specifically including: compound name, molecular formula, SMILES, InChIKey, accurate mass-to-charge ratio of precursor ions, mass-to-charge ratio of characteristic fragment ions and their relative abundance information.

9. A method for annotating glucosinolate compounds, characterized in that, include: Acquire liquid chromatography-tandem mass spectrometry data of the plant samples to be tested; The mass spectrometry data is matched with a glucosinolate secondary mass spectrometry database as described in claim 8, and the glucosinolate compounds in the plant sample to be tested are annotated according to the matching results. The matching process includes: comparing the precise mass-to-charge ratio of the precursor ions, comparing the consistency between the measured secondary mass spectrum and the theoretical secondary mass spectrum information of the glucosinolate secondary mass spectrometry database, and filtering the annotation results according to a preset scoring threshold.

10. The application of the glucosinolate secondary mass spectrometry database of claim 8 in plant metabolomics, glucosinolate structure determination, or mass spectrometry data analysis.